EP. 7 Unmet Needs and Adverse Event Management for Patients With Lower-Risk MDS and Symptomatic Anemia
November 10th, 2026Prizlon-Cel Nets FDA RMAT and Fast Track Designations in R/R LBCLThe anti-CD19/CD20 CAR T-cell therapy will be studied in the phase 2 ABZT-121 trial after progression on commercial CAR T-cell therapy.Read more
November 9th, 2026FDA Flashback: Hematologic Cancer Decisions and News From October 2026Read a refresh of hematologic cancer FDA news from October 2026, including the approval of a noncovalent BTK inhibitor in untreated CLL/SLL.Read more
November 6th, 2026OncLive Weekly News Quiz (11/6/2026): Did You Miss Crucial Hematologic, Lung, and Desmoid Tumor Updates?Did you catch all of this week's top oncology news? Test your knowledge with OncLive's Weekly News Quiz.Read more